VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | Investigating the place of JAK inhibitors in the treatment of myelofibrosis

Jeanne Palmer, MD, Mayo Clinic, Phoenix, AZ, highlights the importance of determining how to use novel JAK inhibitors in myelofibrosis (MF), discussing treatment sequencing, JAK inhibitor choice, and lines of therapy. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter